ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $1,657,000 | +0.9% | 26,024 | -2.2% | 0.36% | -3.7% |
Q4 2014 | $1,643,000 | +59.5% | 26,608 | +0.2% | 0.38% | +38.5% |
Q3 2014 | $1,030,000 | +15.5% | 26,564 | +2.7% | 0.27% | +24.1% |
Q2 2014 | $892,000 | -20.1% | 25,864 | 0.0% | 0.22% | -24.1% |
Q1 2014 | $1,117,000 | – | 25,864 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |